Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T18:47:58.603Z.
Calculation as of: 2026-10-06T18:47:58.603Z.
Quote observation: 2026-10-06T18:45:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 05c00b329f1e3adc6cfa9751fac96b44e9956e0cda8839801cbe896438e656e1
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2022-11-03.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
EV/EBIT RATIO AVG TTM
N/A
EV/EBIT RATIO AVG 3Y
N/A
EV/EBIT RATIO AVG 5Y
N/A
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$1.51B
EV/EBIT Ratio
92.90x
TTM Avg
402.45x
3Y Avg
215.28x
5Y Avg
215.28x
Market Cap
$1.57B
EV/EBIT Ratio
N/A
TTM Avg
40.24x
3Y Avg
40.24x
5Y Avg
40.24x
Market Cap
$1.49B
EV/EBIT Ratio
11.15x
TTM Avg
15.08x
3Y Avg
17.83x
5Y Avg
16.60x
Market Cap
$1.47B
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Syndax Pharmaceuticals, Inc. (SNDX) | $1.54B | N/A | N/A | N/A | N/A |
| Innoviva, Inc. (INVA)vs › | $1.54B | 7.64x | 117.97x | 74.38x | 44.05x |
| Nutex Health, Inc. (NUTX)vs › | $1.53B | 4.58x | 3.98x | 4.35x | 10.88x |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.51B | 92.90x | 402.45x | 215.28x | 215.28x |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.57B | N/A | 40.24x | 40.24x | 40.24x |
| Phibro Animal Health Corporation (PAHC)vs › | $1.49B | 11.15x | 15.08x | 17.83x | 16.60x |
| GH Research PLC (GHRS)vs › | $1.47B | N/A | N/A | N/A | N/A |
| uniQure N.V. (QURE)vs › | $1.63B | N/A | 1.97x | 2.00x | 2.00x |
| Rapport Therapeutics, Inc. Common Stock (RAPP)vs › | $1.47B | N/A | N/A | N/A | N/A |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.61B | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2022-11-03 | 1096.16x |
| 2022-11-02 | 1125.84x |
| 2022-11-01 | 1138.56x |
| 2022-10-31 | 1129.55x |
| 2022-10-28 | 1169.83x |
| 2022-10-27 | 1130.08x |
| 2022-10-26 | 1140.68x |
| 2022-10-25 | 1142.80x |
| 2022-10-24 | 1147.57x |
| 2022-10-21 | 1160.82x |
| 2022-10-20 | 1099.87x |
| 2022-10-19 | 1082.38x |
| 2022-10-18 | 1150.75x |
| 2022-10-17 | 1178.31x |
| 2022-10-14 | 1159.76x |
| 2022-10-13 | 1184.67x |
| 2022-10-12 | 1201.11x |
| 2022-10-11 | 1156.05x |
| 2022-10-10 | 1158.17x |
| 2022-10-07 | 1196.33x |
| 2022-10-06 | 1303.40x |
| 2022-10-05 | 1223.37x |
| 2022-10-04 | 1235.03x |
| 2022-10-03 | 1191.03x |
| 2022-09-30 | 1186.26x |
| 2022-09-29 | 1222.31x |
| 2022-09-28 | 1212.24x |
| 2022-09-27 | 1150.75x |
| 2022-09-26 | 1123.72x |
| 2022-09-23 | 1128.49x |
| 2022-09-22 | 1121.60x |
| 2022-09-21 | 1149.69x |
| 2022-09-20 | 1166.65x |
| 2022-09-19 | 1132.73x |
| 2022-09-16 | 1139.09x |
| 2022-09-15 | 1214.89x |
| 2022-09-14 | 1177.78x |
| 2022-09-13 | 1156.05x |
| 2022-09-12 | 1171.95x |
| 2022-09-09 | 1214.89x |
| 2022-09-08 | 1226.55x |
| 2022-09-07 | 1147.57x |
| 2022-09-06 | 1127.43x |
| 2022-09-02 | 1197.92x |
| 2022-09-01 | 1223.37x |
| 2022-08-31 | 1164.00x |
| 2022-08-30 | 1143.33x |
| 2022-08-29 | 1122.66x |
| 2022-08-26 | 1133.79x |
| 2022-08-25 | 1193.15x |
| 2022-08-24 | 1215.42x |
| 2022-08-23 | 1211.71x |
| 2022-08-22 | 1187.85x |
| 2022-08-19 | 1217.54x |
| 2022-08-18 | 1192.62x |
| 2022-08-17 | 1196.33x |
| 2022-08-16 | 1223.37x |
| 2022-08-15 | 1223.90x |
| 2022-08-12 | 1184.67x |
| 2022-08-11 | 1166.65x |
| 2022-08-10 | 1184.67x |
| 2022-08-09 | 1184.14x |
| 2022-08-08 | 76.51x |
| 2022-08-05 | 75.04x |
| 2022-08-04 | 70.87x |
| 2022-08-03 | 64.76x |
| 2022-08-02 | 62.87x |
| 2022-08-01 | 62.59x |
| 2022-07-29 | 62.55x |
| 2022-07-28 | 65.30x |
| 2022-07-27 | 65.62x |
| 2022-07-26 | 64.80x |
| 2022-07-25 | 65.44x |
| 2022-07-22 | 63.94x |
| 2022-07-21 | 60.73x |
| 2022-07-20 | 58.05x |
| 2022-07-19 | 58.30x |
| 2022-07-18 | 57.02x |
| 2022-07-15 | 57.80x |
| 2022-07-14 | 58.16x |
| 2022-07-13 | 58.30x |
| 2022-07-12 | 57.52x |
| 2022-07-11 | 55.91x |
| 2022-07-08 | 59.20x |
| 2022-07-07 | 60.41x |
| 2022-07-06 | 62.55x |
| 2022-07-05 | 62.55x |
| 2022-07-01 | 57.91x |
| 2022-06-30 | 58.52x |
| 2022-06-29 | 57.95x |
| 2022-06-28 | 55.98x |
| 2022-06-27 | 56.63x |
| 2022-06-24 | 58.12x |
| 2022-06-23 | 57.62x |
| 2022-06-22 | 53.02x |
| 2022-06-21 | 52.20x |
| 2022-06-17 | 49.95x |
| 2022-06-16 | 46.28x |
| 2022-06-15 | 47.77x |
| 2022-06-14 | 46.06x |
| 2022-06-13 | 45.53x |
| 2022-06-10 | 48.27x |
| 2022-06-09 | 51.09x |
| 2022-06-08 | 53.02x |
| 2022-06-07 | 50.38x |
| 2022-06-06 | 46.88x |
| 2022-06-03 | 48.67x |
| 2022-06-02 | 49.09x |
| 2022-06-01 | 48.99x |
| 2022-05-31 | 48.74x |
| 2022-05-27 | 48.10x |
| 2022-05-26 | 44.03x |
| 2022-05-25 | 42.14x |
| 2022-05-24 | 40.42x |
| 2022-05-23 | 41.81x |
| 2022-05-20 | 42.17x |
| 2022-05-19 | 39.17x |
| 2022-05-18 | 38.53x |
| 2022-05-17 | 42.06x |
| 2022-05-16 | 39.89x |
| 2022-05-13 | 40.21x |
| 2022-05-12 | 39.64x |
| 2022-05-11 | 39.10x |
| 2022-05-10 | 43.88x |
| 2022-05-09 | 22.98x |
| 2022-05-06 | 24.95x |
| 2022-05-05 | 26.02x |
| 2022-05-04 | 27.85x |
| 2022-05-03 | 27.34x |
| 2022-05-02 | 27.20x |
| 2022-04-29 | 26.35x |
| 2022-04-28 | 26.65x |
| 2022-04-27 | 25.49x |
| 2022-04-26 | 25.39x |
| 2022-04-25 | 26.28x |
| 2022-04-22 | 25.64x |
| 2022-04-21 | 26.14x |
| 2022-04-20 | 27.16x |
| 2022-04-19 | 26.77x |
| 2022-04-18 | 27.20x |
| 2022-04-14 | 29.12x |
| 2022-04-13 | 29.59x |
| 2022-04-12 | 27.81x |
| 2022-04-11 | 28.25x |
| 2022-04-08 | 27.85x |
| 2022-04-07 | 30.50x |
| 2022-04-06 | 31.19x |
| 2022-04-05 | 31.84x |
| 2022-04-04 | 31.11x |
| 2022-04-01 | 28.07x |
| 2022-03-31 | 27.58x |
| 2022-03-30 | 27.32x |
| 2022-03-29 | 29.35x |
| 2022-03-28 | 27.48x |
| 2022-03-25 | 28.03x |
| 2022-03-24 | 28.45x |
| 2022-03-23 | 28.03x |
| 2022-03-22 | 28.84x |
| 2022-03-21 | 26.71x |
| 2022-03-18 | 26.22x |
| 2022-03-17 | 26.41x |
| 2022-03-16 | 26.95x |
| 2022-03-15 | 24.95x |
| 2022-03-14 | 24.32x |
| 2022-03-11 | 26.51x |
| 2022-03-10 | 27.79x |
| 2022-03-09 | 27.44x |
| 2022-03-08 | 26.81x |
| 2022-03-07 | 25.74x |
| 2022-03-04 | 23.26x |
| 2022-03-03 | 24.97x |
| 2022-03-02 | 25.01x |
